NPI: 1902870330 · SAN DIEGO, CA 92115 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,121 | $3.22M |
| 2019 | 25,662 | $2.38M |
| 2020 | 20,603 | $1.70M |
| 2021 | 21,315 | $1.49M |
| 2022 | 23,294 | $1.70M |
| 2023 | 21,001 | $2.20M |
| 2024 | 17,205 | $2.25M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 64,455 | 5,772 | $13.97M |
| 90945 | 2,584 | 115 | $400K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,037 | 2,799 | $170K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,912 | 1,183 | $107K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,920 | 1,586 | $94K |
| J1756 | Injection, iron sucrose, 1 mg | 10,345 | 3,195 | $72K |
| A4657 | Syringe, with or without needle, each | 4,692 | 2,118 | $72K |
| 0250 | 6,013 | 422 | $24K | |
| 83970 | 1,465 | 1,345 | $7K | |
| 82728 | 1,156 | 1,077 | $2K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 226 | 146 | $1K |
| 83550 | 1,080 | 1,001 | $1K | |
| 83540 | 1,184 | 1,100 | $957.36 | |
| 85041 | 1,490 | 1,374 | $883.03 | |
| 85048 | 1,440 | 1,326 | $723.27 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 201 | 188 | $508.94 |
| 90674 | 87 | 87 | $141.47 | |
| 90662 | 83 | 80 | $61.83 | |
| 90661 | 15 | 15 | $55.27 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 651 | 510 | $28.84 |
| 82108 | 92 | 90 | $17.27 | |
| G0008 | Administration of influenza virus vaccine | 49 | 49 | $10.32 |
| 82746 | 12 | 12 | $0.00 | |
| 82607 | 12 | 12 | $0.00 |